Skip to main content
Code
2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA
2024 Interactive ABPI Code of Practice
Documents outlining the changes to the ABPI Code
Previous Codes of Practice
Guidance and Q&As
Guidance
Q&As by Topic OR Clause
2024 Code Clause 12 Q&As
2024 Code Clause 10.4 Q&As
Cases
Ongoing cases
Completed cases
Advertised Sanctions
Complaints procedure
Before you send us your complaint, have you come to the right place?
Make a complaint
Responding to a complaint
Abridged complaints procedure
Pilot Limitation Period Policy
Intercompany complaints
Intercompany dialogue
Compliance with intercompany undertakings
Appeal procedures
Administrative charges
Sanctions
Privacy Policy for Complaints
Search the site
About us
Media
Publications
Training
Contact us
eAlert
Code
2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA
2024 Interactive ABPI Code of Practice
Documents outlining the changes to the ABPI Code
Previous Codes of Practice
Guidance and Q&As
Guidance
Q&As by Topic OR Clause
2024 Code Clause 12 Q&As
2024 Code Clause 10.4 Q&As
Cases
Ongoing cases
Completed cases
Advertised Sanctions
Complaints procedure
Before you send us your complaint, have you come to the right place?
Make a complaint
Responding to a complaint
Abridged complaints procedure
Pilot Limitation Period Policy
Intercompany complaints
Intercompany dialogue
Compliance with intercompany undertakings
Appeal procedures
Administrative charges
Sanctions
Privacy Policy for Complaints
The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 and changes to and impact on the 2019 ABPI Code of Practice for the Pharmaceutical Industry
16 February 2021
Click for further information
